Table 2.
Insulin levels in 6 human serums tested by chemiluminescence immunoassays (CIA) and the developed immune-MS method
| Serums of patients (accepting insulin therapy) | ||||||
|---|---|---|---|---|---|---|
| #1 | #2 | #3 | #4 | #5 | #6 | |
| CIA (nM)a | 1.0 | 3.6 | 3.2 | 2.1 | 3.5 | 2.3 |
| MS (nM)b | 1.3 | 3.8 | 3.3 | 2.2 | 3.8 | 2.4 |
5 Duplicates of each sample were tested by MALDI MS based on antibody-modified target plate and CIA
a CIA chemiluminescence ImmunoAssays
b MS MALDI MS based on antibody-modified target plate